STS specialized in toxicology and preclinical regulatory affairs. It provided consulting services for the design, conduct, reporting and evaluation of toxicity and other safety testing studies. Its objective was to help its clients bring their best potential products to market in a cost efficient manner and well within their patented time frame. This ensured the necessary return on investment and provided funds for developing future compounds.
STS was dedicated to helping companies maintain reasonable yet practical research and development budgets. Knowing the constraints placed upon its clients by today's regulatory requirements and market conditions STS concentrated on providing the most effective support services.
STS was headed by Barry E. Osborne, PhD, who had spent more than 32 years in toxicology and other safety testing research, working in three major contract research laboratories (two in the UK, one in Canada) and establishing a new and successful testing laboratory in Frederick, Maryland, USA. During this period he gained "hands-on" experience in the design, performance, reporting and evaluation of all relevant types of toxicity studies. Broad knowledge of international testing regulations and Good Laboratory Practices (GLP's) was acquired and research programs undertaken on a broad range of pharmaceutical, biotechnology products, chemicals and biomaterials. Extensive travel throughout N. America, Europe and Asia provided him with the necessary understanding of the needs of not only multinational companies but also new and emerging companies whose resources tend to be more limited. During the past additional 8 years Dr. Osborne also developed expertise in preclinical regulatory affairs.
Further information can be obtained by contacting:
JOY OSBORNE,
SAFETY TESTING SERVICES INC.,
2639 BELMONT,
ST. LAZARE, QUE., J7T 2A1, CANADA.
Tel: 450-458-1613
Fax: 450-458-4137
E-Mail: toxozzy@consult-toxicology.com
